Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis

Overview of attention for article published in Drug Design, Development and Therapy, September 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 2 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Patents Facebook Dimensions citations

So far, Dimensions has found 27 publications that cite this research output.

27

The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Article in The Turkish Journal of Gastroenterology (February 2023)

Safety and efficacy of switching to pemafibrate from bezafibrate in patients with chronic liver disease

Article in Hepatology Research (November 2022)

Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis

Article in Digestive Diseases and Sciences (September 2022)